{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Computed tomography", "Glioblastoma", "Nuclear magnetic resonance", "Phytotherapy", "Recurrence"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29433556", "DateCompleted": {"Year": "2018", "Month": "08", "Day": "28"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "02", "Day": "13"}], "Language": ["eng"], "ELocationID": ["28", "10.1186/s12957-018-1329-2"], "Journal": {"ISSN": "1477-7819", "JournalIssue": {"Volume": "16", "Issue": "1", "PubDate": {"Year": "2018", "Month": "Feb", "Day": "13"}}, "Title": "World journal of surgical oncology", "ISOAbbreviation": "World J Surg Oncol"}, "ArticleTitle": "Treatment of glioblastoma with herbal medicines.", "Pagination": {"StartPage": "28", "MedlinePgn": "28"}, "Abstract": {"AbstractText": ["In the latest years, a lot of research studies regarding the usage of active agents from plants in the treatment of tumors have been published, but there is no data about successful usage of herbal remedies in the treatment of glioblastoma in humans.", "The phytotherapy involved five types of herbal medicine which the subjects took in the form of tea, each type once a day at regular intervals. Three patients took herbal medicine along with standard oncological treatment, while two patients applied for phytotherapy after completing medical treatment. The composition of herbal medicine was modified when necessary, which depended on the results of the control scans using the nuclear magnetic resonance technique and/or computed tomography.", "Forty-eight months after the introduction of phytotherapy, there were no clinical or radiological signs of the disease, in three patients; in one patient, the tumor was reduced and his condition was stable, and one patient lived for 48\u00a0months in spite of a large primary tumor and a massive recurrence, which developed after the treatment had been completed.", "The results achieved in patients in whom tumor regression occurred exclusively through the use of phytotherapy deserve special attention. In order to treat glioblastoma more effectively, it is necessary to develop innovative therapeutic strategies and medicines that should not be limited only to the field of conventional medicine. The results presented in this research paper are encouraging and serve as a good basis for further research on the possibilities of phytotherapy in the treatment of glioblastoma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Family business \"DREN\" Ltd, \u017dep\u010de, Bosnia and Herzegovina."}], "LastName": "Trogrli\u0107", "ForeName": "Ivo", "Initials": "I"}, {"Identifier": ["0000-0002-4363-7103"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Family business \"DREN\" Ltd, \u017dep\u010de, Bosnia and Herzegovina. dragan.trogrlic@tel.net.ba."}], "LastName": "Trogrli\u0107", "ForeName": "Dragan", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Family business \"DREN\" Ltd, \u017dep\u010de, Bosnia and Herzegovina."}], "LastName": "Trogrli\u0107", "ForeName": "Darko", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Family business \"DREN\" Ltd, \u017dep\u010de, Bosnia and Herzegovina."}], "LastName": "Trogrli\u0107", "ForeName": "Amina Kadri\u0107", "Initials": "AK"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "World J Surg Oncol", "NlmUniqueID": "101170544", "ISSNLinking": "1477-7819"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adolescent"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Follow-Up Studies"}, {"QualifierName": ["drug therapy", "pathology"], "DescriptorName": "Glioblastoma"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prognosis"}, {"QualifierName": [], "DescriptorName": "Survival Rate"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Not applicable. CONSENT FOR PUBLICATION: Consent for publication had been obtained from every participant in the study. COMPETING INTERESTS: The authors declare that they have no competing interests. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol. 2007;114(2):97\u2013109. doi: 10.1007/s00401-007-0243-4.", "ArticleIdList": ["10.1007/s00401-007-0243-4", "PMC1929165", "17618441"]}, {"Citation": "Ohgaki H, Watanabe K, Peraud A, Biernat W, von Deimling A, Yasargil MG, Yonekawa Y, Kleihues P. A case history of glioma progression. Acta Neuropathol. 1999;87:525\u2013532. doi: 10.1007/s004010051024.", "ArticleIdList": ["10.1007/s004010051024", "10334492"]}, {"Citation": "Tso CL, Freije WA, Day A, Chen Z, Merriman B, Perlina A, Lee Y, Dia EQ, Yoshimoto K, Mischel PS, Liau LM, Cloughesy TF, Nelson SF. Distinct transcription profiles of primary and secondary glioblastoma subgroups. Cancer Res. 2006;66:159\u201367.", "ArticleIdList": ["16397228"]}, {"Citation": "Ohgaki H, Kleihues P. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445\u20131453. doi: 10.2353/ajpath.2007.070011.", "ArticleIdList": ["10.2353/ajpath.2007.070011", "PMC1854940", "17456751"]}, {"Citation": "McLendon RE, Halperin EC. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer. 2003;98(8):1745\u20131748. doi: 10.1002/cncr.11666.", "ArticleIdList": ["10.1002/cncr.11666", "14534892"]}, {"Citation": "Stupp R, Mason WP, van den Bent MJ. European Organisation for Reserch and Treatment of Cancer Brain Tumor and Radiotherapy Groups, National Cancer Institute of Canadian Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u2013996. doi: 10.1056/NEJMoa043330.", "ArticleIdList": ["10.1056/NEJMoa043330", "15758009"]}, {"Citation": "Oh J, Sahgal A, Sanghera P, Tsao MN, Davey P, Lam K, Symons S, Aviv R, Perry JR. Glioblastoma: patterns of recurrence and efficacy of salvage treatments. Can J Neurol Sci. 2011;38:621\u2013625. doi: 10.1017/S0317167100012166.", "ArticleIdList": ["10.1017/S0317167100012166", "21672702"]}, {"Citation": "Blanc JL, Wager M, Guilhot J, Kusy S, Bataille B, Chantereau T, Lapierre F, Larsen CJ, Karayan-Tapon L. Correlation of clinical features andmethylation status of MGMT gene promoter in glioblastomas. J Neuro-Oncol. 2004;68:275\u2013283. doi: 10.1023/B:NEON.0000033385.37098.85.", "ArticleIdList": ["10.1023/B:NEON.0000033385.37098.85", "15332332"]}, {"Citation": "Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene. 2002;21(35):5400\u20135413. doi: 10.1038/sj.onc.1205651.", "ArticleIdList": ["10.1038/sj.onc.1205651", "12154403"]}, {"Citation": "Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352:997\u20131003. doi: 10.1056/NEJMoa043331.", "ArticleIdList": ["10.1056/NEJMoa043331", "15758010"]}, {"Citation": "Grasbon-Frodl EM, Kreth FW, Ruiter M, Schnell O, Bise K, Felsberg J, Reifenberger G, Tonn JC, Kretzschmar HA. Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas. Int J Cancer. 2005;121:2458\u20132464. doi: 10.1002/ijc.23020.", "ArticleIdList": ["10.1002/ijc.23020", "17691113"]}, {"Citation": "Neff T, Beard BC, Peterson LJ, Anandakumar P, Thompson J, Kiem HP. Polyclonal chemoprotection against temozolomide in a large-animal model of drug resistance gene therapy. Blood. 2005;105:997\u20131002. doi: 10.1182/blood-2004-08-3169.", "ArticleIdList": ["10.1182/blood-2004-08-3169", "15494421"]}, {"Citation": "Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Sampson JH, McLendon RE, Herndon JE, 2nd, Friedman HS. Phase 1 trial of temozolomide (TMZ) plus irinotecan (CPT-11) plus O6-benzylguanine (O6-BG) in adults with recurrent malignant glioma. Cancer. 2009;115(13):2964\u20132970. doi: 10.1002/cncr.24336.", "ArticleIdList": ["10.1002/cncr.24336", "PMC2748258", "19402172"]}, {"Citation": "Kim SH, Chun SY, Kim TS. Interferon-alpha enhances artemisinin-induced differentiation of HL-60 leukemia cells via a PKC alpha/ERK pathway. Eur J Pharmacol. 2008;587:65\u201372. doi: 10.1016/j.ejphar.2008.03.036.", "ArticleIdList": ["10.1016/j.ejphar.2008.03.036", "18456255"]}, {"Citation": "Sadava D, Phillips T, Lin C, Kane SE. Transferrin overcomes drug resistance to artemisinin in human small-cell lung carcinoma cells. Cancer Lett. 2002;179:151\u2013156. doi: 10.1016/S0304-3835(02)00005-8.", "ArticleIdList": ["10.1016/S0304-3835(02)00005-8", "11888669"]}, {"Citation": "Z-S Z, Wang J, Y-B S, et al. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett. 2015;10(1):379\u2013383. doi: 10.3892/ol.2015.3183.", "ArticleIdList": ["10.3892/ol.2015.3183", "PMC4487108", "26171034"]}, {"Citation": "Xie LH, Li Q, Zhang J, Weina PJ. Pharmacokinetics, tissue distribution and mass balance of radiolabeled dihydroartemisinin in male rats. Malar J. 2009;8:112. doi: 10.1186/1475-2875-8-112.", "ArticleIdList": ["10.1186/1475-2875-8-112", "PMC2694832", "19470172"]}, {"Citation": "Reichert S, Reinboldt V, Hehlgans S, Efferth T, Rodel C, Rodel F. A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein survivin. Radiother Oncol. 2012;103:394\u2013401. doi: 10.1016/j.radonc.2012.03.018.", "ArticleIdList": ["10.1016/j.radonc.2012.03.018", "22560712"]}, {"Citation": "Huang XJ, Li CT, Zhang WP, Lu YB, Fang SH, Wei EQ. Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells. Pharmacology. 2008;82:1\u20139. doi: 10.1159/000125673.", "ArticleIdList": ["10.1159/000125673", "18408414"]}, {"Citation": "Trogrlic I, Trogrlic D, Trogrlic Z. Treatment of progression of diffuse astrocytoma by herbal medicine: case report. Afr J Tradit Complement Altern Med. 2016;13:1\u20134. doi: 10.21010/ajtcam.v13i6.1.", "ArticleIdList": ["10.21010/ajtcam.v13i6.1", "PMC5412178", "28480352"]}, {"Citation": "Trogrli\u0107 I, Trogrli\u0107 D, Trogrli\u0107 Z. The influence of phytotherapy on macroprolactinoma size. Afr J Tradit Complement Altern Med. 2012;9(2):277\u2013286.", "ArticleIdList": ["PMC3746621", "23983347"]}, {"Citation": "Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer. 2000;83(5):588\u2013593. doi: 10.1054/bjoc.2000.1316.", "ArticleIdList": ["10.1054/bjoc.2000.1316", "PMC2363506", "10944597"]}, {"Citation": "Perry JR, B\u00e9langer K, Mason WP, Fulton D, Kavan P, Easaw J, Shields C, Kirby S, Macdonald DR, Eisenstat DD, Thiessen B, Forsyth P, Pouliot JF. Phase II trial of continuous dose-intense temozolomide in recurrent malignant glioma: RESCUE study. J Clin Onc. 2010;28(12):2051\u20132057. doi: 10.1200/JCO.2009.26.5520.", "ArticleIdList": ["10.1200/JCO.2009.26.5520", "20308655"]}, {"Citation": "Borrelli F, Izzo AA. Herb\u2013drug interactions with St John\u2019s wort (Hypericum perforatum): an update on clinical observations. AAPS J. 2009;11(4):710. doi: 10.1208/s12248-009-9146-8.", "ArticleIdList": ["10.1208/s12248-009-9146-8", "PMC2782080", "19859815"]}, {"Citation": "Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonz\u00e1lez Gonz\u00e1lez D. Prognostic factors in glioblastoma multiforme.10 years experience of a single institution. Strahlenther Onkol. 2001;177(6):283\u2013290. doi: 10.1007/PL00002409.", "ArticleIdList": ["10.1007/PL00002409", "11446316"]}, {"Citation": "Karsy M, Neil JA, Guan J, Mahan MA, Colman H, Jensen RL. A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus. 2015;38:E4. doi: 10.3171/2015.1.FOCUS14755.", "ArticleIdList": ["10.3171/2015.1.FOCUS14755", "25727226"]}, {"Citation": "Wood JR, Green SB, Shapiro WR. The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the brain tumor cooperative group. J Clin Oncol. 1988;6(2):338\u2013343. doi: 10.1200/JCO.1988.6.2.338.", "ArticleIdList": ["10.1200/JCO.1988.6.2.338", "3339397"]}, {"Citation": "W\u00fcrschmidt F, B\u00fcnemann H, Heilmann HP. Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy. Strhlentherapie und Onkologie. 1995;171(6):315\u2013321.", "ArticleIdList": ["7597616"]}, {"Citation": "Swanson KR, Alvord EC, Jr, Murrau JD. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer. 2002;86:14\u201318. doi: 10.1038/sj.bjc.6600021.", "ArticleIdList": ["10.1038/sj.bjc.6600021", "PMC2746525", "11857005"]}, {"Citation": "Seidel C, D\u00f6rner N, Osswald M, Wick A, Platten M, Bendszus M, Wick W. Does age matter?\u2014a MRI study on peritumoral edema in newly diagnosed primary glioblastoma. BMC Cancer. 2011;11(1):127\u2013131. doi: 10.1186/1471-2407-11-127.", "ArticleIdList": ["10.1186/1471-2407-11-127", "PMC3094323", "21481277"]}, {"Citation": "Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD. North American Brain Tumor Consortium. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro-Oncology. 2011;13(10):1118\u20131124. doi: 10.1093/neuonc/nor110.", "ArticleIdList": ["10.1093/neuonc/nor110", "PMC3177665", "21813511"]}, {"Citation": "Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schuler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lutolf U, Kleihues P, Ohgaki H. Population-based study on incidence, survival rates, and genetic alterations of low-grade astrocytomas and oligodendrogliomas. Acta Neuropathol. 2004;108:49\u201356. doi: 10.1007/s00401-004-0861-z.", "ArticleIdList": ["10.1007/s00401-004-0861-z", "15118874"]}, {"Citation": "Schoenegger K, Oberndorfer S, Wuschitz B, Struhal W, Hainfellner J, Prayer D, Heinzl H, Lahrmann H, Marosi C, Grisold W. Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma? Eur J Neurol. 2009;16(7):874\u2013878. doi: 10.1111/j.1468-1331.2009.02613.x.", "ArticleIdList": ["10.1111/j.1468-1331.2009.02613.x", "19473360"]}, {"Citation": "Efferth T, Sch\u00f6ttler U, Krishna S, Schmiedek P, Wenz F, Giordano FA. Hepatotoxicity by combination treatment of temozolomide, artesunate and Chinese herbs in a glioblastoma multiforme patient: case report review of the literature. Arch Toxicol. 2017;91(4):1833\u20131846. doi: 10.1007/s00204-016-1810-z.", "ArticleIdList": ["10.1007/s00204-016-1810-z", "27519711"]}]}], "History": [{"Year": "2017", "Month": "12", "Day": "6"}, {"Year": "2018", "Month": "2", "Day": "4"}, {"Year": "2018", "Month": "2", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "8", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "13"}], "PublicationStatus": "epublish", "ArticleIdList": ["29433556", "PMC5809810", "10.1186/s12957-018-1329-2", "10.1186/s12957-018-1329-2"]}}]}